Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

supplemental oxygen

PreclinicalSmall molecule

CCES University

supplemental oxygen is one of 2 small molecule programs targeting Orthopedic Surgery. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Orthopedic SurgeryUnknown status

Orthopedic SurgeryPreclinical

Unknown status

Competition

Competitive Landscape

1 competitor in Orthopedic Surgery

#DrugCompanyPhaseTrials

Analgesics

UUniversity of Colorado, Denver

supplemental oxygen

CCES University

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Orthopedic Surgery1 trial

Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery

Unknown status·—·N/A·NCT01734954·66 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for supplemental oxygen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — supplemental oxygen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for supplemental oxygen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — CES University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCES University

Related News